Detalhe da pesquisa
1.
FXR inhibition may protect from SARS-CoV-2 infection by reducing ACE2.
Nature
; 615(7950): 134-142, 2023 03.
Artigo
Inglês
| MEDLINE | ID: mdl-36470304
2.
Refractory hepatic hydrothorax is associated with increased mortality with death occurring at lower MELD-Na compared to cirrhosis and refractory ascites.
Hepatology
; 79(4): 844-856, 2024 Apr 01.
Artigo
Inglês
| MEDLINE | ID: mdl-37625139
3.
Liver Stiffness Measurement and Risk Prediction of Hepatocellular Carcinoma After HCV Eradication in Veterans With Cirrhosis.
Clin Gastroenterol Hepatol
; 22(4): 778-788.e7, 2024 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-38061410
4.
Hepatocellular Carcinoma Diagnosis and Management in 2021: A National Veterans Affairs Quality Improvement Project.
Clin Gastroenterol Hepatol
; 22(2): 324-338, 2024 02.
Artigo
Inglês
| MEDLINE | ID: mdl-37460005
5.
Comparison of infection-induced and vaccine-induced immunity against COVID-19 in patients with cirrhosis.
Hepatology
; 77(1): 186-196, 2023 01 01.
Artigo
Inglês
| MEDLINE | ID: mdl-35712794
6.
Ursodeoxycholic acid is associated with a reduction in SARS-CoV-2 infection and reduced severity of COVID-19 in patients with cirrhosis.
J Intern Med
; 293(5): 636-647, 2023 05.
Artigo
Inglês
| MEDLINE | ID: mdl-37018129
7.
Accurate long-term prediction of death for patients with cirrhosis.
Hepatology
; 76(3): 700-711, 2022 09.
Artigo
Inglês
| MEDLINE | ID: mdl-35278226
8.
Postvaccination COVID-19 infection is associated with reduced mortality in patients with cirrhosis.
Hepatology
; 76(1): 126-138, 2022 07.
Artigo
Inglês
| MEDLINE | ID: mdl-35023206
9.
Association between sustained virological response and clinical outcomes in patients with hepatitis C infection and hepatocellular carcinoma.
Cancer
; 128(19): 3470-3478, 2022 10 01.
Artigo
Inglês
| MEDLINE | ID: mdl-35796530
10.
Third dose of COVID-19 mRNA vaccine appears to overcome vaccine hyporesponsiveness in patients with cirrhosis.
J Hepatol
; 77(5): 1349-1358, 2022 11.
Artigo
Inglês
| MEDLINE | ID: mdl-36181987
11.
Male Sex Is Associated With Higher Rates of Liver-Related Mortality in Primary Biliary Cholangitis and Cirrhosis.
Hepatology
; 74(2): 879-891, 2021 08.
Artigo
Inglês
| MEDLINE | ID: mdl-33636012
12.
Rates of decompensation, hepatocellular carcinoma and mortality in AMA-negative primary biliary cholangitis cirrhosis.
Liver Int
; 42(2): 384-393, 2022 02.
Artigo
Inglês
| MEDLINE | ID: mdl-34614294
13.
Hepatocellular carcinoma tumour volume doubling time: a systematic review and meta-analysis.
Gut
; 70(2): 401-407, 2021 02.
Artigo
Inglês
| MEDLINE | ID: mdl-32398224
14.
Predicting survival after liver transplantation in patients with hepatocellular carcinoma using the LiTES-HCC score.
J Hepatol
; 74(6): 1398-1406, 2021 06.
Artigo
Inglês
| MEDLINE | ID: mdl-33453328
15.
Effects of Metformin Exposure on Survival in a Large National Cohort of Patients With Diabetes and Cirrhosis.
Clin Gastroenterol Hepatol
; 19(10): 2148-2160.e14, 2021 10.
Artigo
Inglês
| MEDLINE | ID: mdl-32798709
16.
Diagnostic Performance of Vibration-Controlled Transient Elastography in Liver Transplant Recipients.
Clin Gastroenterol Hepatol
; 19(2): 367-374, 2021 02.
Artigo
Inglês
| MEDLINE | ID: mdl-32272251
17.
Rates and Predictors of Undergoing Different Hepatocellular Carcinoma Screening Tests in Patients With Cirrhosis.
Am J Gastroenterol
; 116(2): 411-415, 2021 02 01.
Artigo
Inglês
| MEDLINE | ID: mdl-33252455
18.
Ursodeoxycholic Acid Response Is Associated With Reduced Mortality in Primary Biliary Cholangitis With Compensated Cirrhosis.
Am J Gastroenterol
; 116(9): 1913-1923, 2021 09 01.
Artigo
Inglês
| MEDLINE | ID: mdl-33989225
19.
Development and Validation of a Model to Predict Long-Term Survival After Liver Transplantation.
Liver Transpl
; 27(6): 797-807, 2021 06.
Artigo
Inglês
| MEDLINE | ID: mdl-33540489
20.
Hepatocellular Carcinoma Demonstrates Heterogeneous Growth Patterns in a Multicenter Cohort of Patients With Cirrhosis.
Hepatology
; 72(5): 1654-1665, 2020 11.
Artigo
Inglês
| MEDLINE | ID: mdl-32017165